Immunome discovers spike/nonspike SARS-CoV-2 antibodies

By The Science Advisory Board staff writers

February 18, 2021 -- Immunome has isolated potent antibodies that are capable of neutralizing several SARS-CoV-2 variants, including the South African variant (B.1.351), in pseudovirus testing.

The company discovered these antibodies by analyzing serum from SARS-CoV-2 "super-responders" who recovered from COVID-19 and mounted a robust immune response to a broad range of viral targets.

In July 2020, the company was awarded a $13.3 million technology award from the U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in collaboration with the Defense Health Agency.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.